Hypersensitivity: Anaphylactoid symptoms (erythema, chills, dyspnea), edema, urticaria, feeling of warmth or photosensitivity may rarely occur and rash or pruritus may infrequently occur. In the event of such symptoms, discontinue the medication.
Dermatologic: It has been reported that Levofloxacin may rarely cause Lyell Syndrome or Stevens Johnson Syndrome.
Psychoneurologic: Convulsion, tremor or numbness may rarely occur, and insomnia, dizziness or headache may infrequently occur.
Renal: An increase in BUN may frequently occur. It has been reported that Levofloxacin may rarely cause acute renal failure.
Hepatic: an increase in S-GOT, GPT, Al-P or y-GTP or total bilirubin may infrequently occur.
Hematologic: A decrease in leukocytes, erythrocytes, hemoglobin or hematocrit or an increase in eosinophils may infrequently occur. Observe patients carefully, and if any abnormality is observed, discontinue the medication.
Gastro-intestinal: Nausea, vomiting, abdominal discomfort, diarrhea, anorexia, abdominal pain or enlarged feeling of the abdomen may infrequently occur. Since it has been reported that Levofloxacin may rarely cause severe colitis, with blood in the stool, such as pseudomembranous colitis, in the event of abdominal pain or frequent diarrhea take appropriate measures, including immediate discontinuation of the medication.
Muscular: Since rhabdomyolysis with rapid deterioration of renal function characterized by myalgia, weakness, increase in CPK or myoglobin in blood or urine may occur, patients should be cautioned.
Others: 1) Since it has been reported that other new quinolones may rarely cause hypoglycemia (especially in elderly patients with renal disorders), this product should be administered carefully. Malaise may rarely occur.
View ADR Monitoring Form